Page All:
Page 1
SMi Group Announce Social Media in the Pharmaceutical Industry: Evolving a Pharma Communications Strategy for the 21st Century Conference, 6th & 7th July 2011
LONDON, May 18, 2011/PRNewswire/ --
For more information visit
http://www.smi-online.co.uk/2011socialmedia32.asp
Building on the tremendous success of SMi's "sell-out" inaugural Social
Media in the Pharmaceutical Industry conference. SMi Group is delighted to
announce their Social Media in the Pharmaceutical Industry: Evolving a
Pharmaceutical Communications Strategy for the 21st Century. This follow-up
event is focused on keeping our audience up-to-date with developments in the
ever-changing social media sphere. The conference is the premier event of its
kind in Europe and the only event to focus exclusively on how social media
can be used within the pharmaceutical industry and healthcare to foster
patient-doctor interaction, knowledge of new treatments and also a greater
understanding of various healthcare issues.
Social media is an area of communications in a state of continual
evolution and flux and 2011 looks set to be a year of immense significance
for the future of its application to the pharmaceutical and healthcare
industry. With the long-awaited FDA guidance on social media finally expected
to be released during the first quarter of 2011, the early implications of
the recommendations and what they mean to those engaged in social media
activities will become apparent over the course of the year.
Key topics to be addressed include:
- Social media marketing: ways to use and integrate social media
platforms into your marketing strategy, ensuring an attractive ROI
- Social media monitoring: methods to measure your impact in the social
media sphere, and effective ROI determination
- Social networking software and platforms: case studies illustrating
different uses for various social media sites and platforms
- Corporate communications: successfully developing a social media
element to your corporate communications strategy
- Interacting with patient groups: understanding the importance of
interacting with online patient groups, and developing a conversational
interaction
This high level conference programme will be delivered by some of the
industry's senior professionals including:
Tim Lloyd, Deputy Head of Publishing & eCommunications, Department of
Health, UK
Marc Monseau, Director, Corporate Communications and Social Media,
Johnson & Johnson
Andrew Widger, Director, Media Relations, EMEA, Pfizer
Alex Butler, EMEA Marketing Communications Manager, Johnson & Johnson
Pharmaceuticals
John Vieira, Senior Director, Marketing Operations & Strategic Services,
Daiichi Sankyo
Cressida Robson, Director, European Communications, Eisai
For further information visit:
http://www.smi-online.co.uk/2011socialmedia32.asp, or alternatively contact:
Mohammad Saffaf on Tel: +44-(0)20-7827-6022 or Email:
msaffaf@smi-online.co.uk
Source: SMi Group
.
SMi Group Announce Social Media in the Pharmaceutical Industry: Evolving a Pharma Communications Strategy for the 21st Century Conference, 6th & 7th July 2011
LONDON, May 18, 2011/PRNewswire/ --
For more information visit
http://www.smi-online.co.uk/2011socialmedia32.asp
Building on the tremendous success of SMi's "sell-out" inaugural Social
Media in the Pharmaceutical Industry conference. SMi Group is delighted to
announce their Social Media in the Pharmaceutical Industry: Evolving a
Pharmaceutical Communications Strategy for the 21st Century. This follow-up
event is focused on keeping our audience up-to-date with developments in the
ever-changing social media sphere. The conference is the premier event of its
kind in Europe and the only event to focus exclusively on how social media
can be used within the pharmaceutical industry and healthcare to foster
patient-doctor interaction, knowledge of new treatments and also a greater
understanding of various healthcare issues.
Social media is an area of communications in a state of continual
evolution and flux and 2011 looks set to be a year of immense significance
for the future of its application to the pharmaceutical and healthcare
industry. With the long-awaited FDA guidance on social media finally expected
to be released during the first quarter of 2011, the early implications of
the recommendations and what they mean to those engaged in social media
activities will become apparent over the course of the year.
Key topics to be addressed include:
- Social media marketing: ways to use and integrate social media
platforms into your marketing strategy, ensuring an attractive ROI
- Social media monitoring: methods to measure your impact in the social
media sphere, and effective ROI determination
- Social networking software and platforms: case studies illustrating
different uses for various social media sites and platforms
- Corporate communications: successfully developing a social media
element to your corporate communications strategy
- Interacting with patient groups: understanding the importance of
interacting with online patient groups, and developing a conversational
interaction
This high level conference programme will be delivered by some of the
industry's senior professionals including:
Tim Lloyd, Deputy Head of Publishing & eCommunications, Department of
Health, UK
Marc Monseau, Director, Corporate Communications and Social Media,
Johnson & Johnson
Andrew Widger, Director, Media Relations, EMEA, Pfizer
Alex Butler, EMEA Marketing Communications Manager, Johnson & Johnson
Pharmaceuticals
John Vieira, Senior Director, Marketing Operations & Strategic Services,
Daiichi Sankyo
Cressida Robson, Director, European Communications, Eisai
For further information visit:
http://www.smi-online.co.uk/2011socialmedia32.asp, or alternatively contact:
Mohammad Saffaf on Tel: +44-(0)20-7827-6022 or Email:
msaffaf@smi-online.co.uk
Source: SMi Group
.